The Antiretroviral Roll-out for HIV in India
HIVIND is a European Union (EU) funded FP7 project with the main objective of improving adherence to first line antiretrovirals among HIV patients in South India using locally relevant innovative means.
- Gupta S, Palchaudhuri R, Neogi U, Srinivasa H, Ashorn P, De Costa A, Källander C, Shet A. Can HIV reverse transcriptase activity assay be a low-cost alternative of viral load testing. BMJ Open 2016;6:e008795 doi:10.1136/bmjopen-2015-00879.
- Rodrigues R, Poongulali S, Balaji K, Atkins S, Ashorn P, De Costa A. ‘The phone reminder is important, but will others get to know about my illness?’ Patient perceptions of an mHealth antiretroviral treatment support intervention in the HIVIND trial in South India. BMJ Open 2015;5:e007574 doi:10.1136/bmjopen-2015-007574.
- Shet A, De Costa A, Kumarasamy N, Rodrigues R, Rewari BB, Ashorn P, Eriksson B, Diwan V. Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India. BMJ 2014 Oct 24;349:g5978.
- De Costa A, Shet A, Kumarasamy N, Ashorn P, Eriksson B, Bogg L, Diwan VK; HIVIND study team. Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India–the HIVIND study protocol. BMC Med Res Methodol. 2010 Mar 26;10:25.